STAT+: Amy Abernethy, deputy commissioner who aimed to amp up FDA’s tech knowhow, to leave post
Amy Abernethy, the number two official at the Food and Drug Administration, plans to depart the agency in mid-to-late April.
The announcement was made in a memo from Janet Woodcock, the acting Commissioner of the Food and Drug Administration, who called Abernethy “a talented and inspiring leader” and said she takes heart in Abernethy’s “enduring accomplishments.”
